Hemodynamic management of patients with cardiogenic shock centers on vasopressors, inotropes, and mechanical circulatory devices. With respect to inotropic medications, there is little data to guide optimal management and selection of agents. In this podcast we discuss the results of a recent trial that compared milrinone with dobutamine for patients with cardiogenic shock. Which agent was the winner?
You can get CME credit for this episode hereClick here for CME Account Creation Instructions
A plethora of great articles pertaining to the care of critically ill patients were published in 2018. In this podcast, we review some of...
Sepsis results in more than 250,000 deaths each year in the United States. Resuscitation of the septic patient centers on timely recognition, early antibiotic...
The incidence of opioid-associated out-of-hospital cardiac arrests continues to rise. Current guidelines for the resuscitation of patients with OHCA advise the clinician to consider...